chr3-94053229-G-A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_001174150.2(ARL13B):​c.1253G>A​(p.Arg418Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,613,250 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00036 ( 1 hom. )

Consequence

ARL13B
NM_001174150.2 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 1.35
Variant links:
Genes affected
ARL13B (HGNC:25419): (ADP ribosylation factor like GTPase 13B) This gene encodes a member of the ADP-ribosylation factor-like family. The encoded protein is a small GTPase that contains both N-terminal and C-terminal guanine nucleotide-binding motifs. This protein is localized in the cilia and plays a role in cilia formation and in maintenance of cilia. Mutations in this gene are the cause of Joubert syndrome 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05440998).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000359 (524/1461048) while in subpopulation MID AF= 0.00173 (10/5764). AF 95% confidence interval is 0.000941. There are 1 homozygotes in gnomad4_exome. There are 255 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ARL13BNM_001174150.2 linkuse as main transcriptc.1253G>A p.Arg418Gln missense_variant 10/10 ENST00000394222.8 NP_001167621.1 Q3SXY8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ARL13BENST00000394222.8 linkuse as main transcriptc.1253G>A p.Arg418Gln missense_variant 10/101 NM_001174150.2 ENSP00000377769.3 Q3SXY8-1

Frequencies

GnomAD3 genomes
AF:
0.000250
AC:
38
AN:
152084
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.000959
GnomAD3 exomes
AF:
0.000355
AC:
89
AN:
250876
Hom.:
0
AF XY:
0.000398
AC XY:
54
AN XY:
135626
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000521
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000537
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000359
AC:
524
AN:
1461048
Hom.:
1
Cov.:
31
AF XY:
0.000351
AC XY:
255
AN XY:
726854
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.000197
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000403
Gnomad4 OTH exome
AF:
0.000348
GnomAD4 genome
AF:
0.000250
AC:
38
AN:
152202
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.000328
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.000353
Gnomad4 OTH
AF:
0.000949
Alfa
AF:
0.000344
Hom.:
0
Bravo
AF:
0.000257
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000412
AC:
50
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.00130

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2022ARL13B: BP4, BP5 -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJan 08, 2024In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 18674751) -
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Joubert syndrome 8 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 12, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 25, 2022This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 418 of the ARL13B protein (p.Arg418Gln). This variant is present in population databases (rs142510905, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with ARL13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 546147). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 25, 2023The c.1253G>A (p.R418Q) alteration is located in exon 10 (coding exon 10) of the ARL13B gene. This alteration results from a G to A substitution at nucleotide position 1253, causing the arginine (R) at amino acid position 418 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.081
.;.;T;T
Eigen
Benign
0.18
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.81
T;T;.;T
M_CAP
Benign
0.081
D
MetaRNN
Benign
0.054
T;T;T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
1.7
.;.;L;L
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.4
N;N;N;N
REVEL
Benign
0.14
Sift
Benign
0.051
T;T;T;T
Sift4G
Uncertain
0.026
D;D;D;D
Polyphen
1.0, 0.95
.;D;P;P
Vest4
0.14
MVP
0.73
MPC
0.24
ClinPred
0.21
T
GERP RS
3.0
Varity_R
0.077
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142510905; hg19: chr3-93772073; COSMIC: COSV57397278; COSMIC: COSV57397278; API